Works by Pitt, Bertram

Results: 277
    1
    2

    Soluble guanylate cyclase: a potential therapeutic target for heart failure.

    Published in:
    Heart Failure Reviews, 2013, v. 18, n. 2, p. 123, doi. 10.1007/s10741-012-9323-1
    By:
    • Gheorghiade, Mihai;
    • Marti, Catherine;
    • Sabbah, Hani;
    • Roessig, Lothar;
    • Greene, Stephen;
    • Böhm, Michael;
    • Burnett, John;
    • Campia, Umberto;
    • Cleland, John;
    • Collins, Sean;
    • Fonarow, Gregg;
    • Levy, Phillip;
    • Metra, Marco;
    • Pitt, Bertram;
    • Ponikowski, Piotr;
    • Sato, Naoki;
    • Voors, Adriaan;
    • Stasch, Johannes-Peter;
    • Butler, Javed
    Publication type:
    Article
    3
    4
    5
    6

    Non-fatal cardiovascular events preceding sudden cardiac death in patients with an acute myocardial infarction complicated by heart failure: insights from the high-riskmyocardial infarction database.

    Published in:
    European Heart Journal: Acute Cardiovascular Care, 2021, v. 10, n. 2, p. 127, doi. 10.1093/ehjacc/zuaa012
    By:
    • Hui, Sonya K.;
    • Sharma, Abhinav;
    • Docherty, Kieran;
    • McMurray, John J. V.;
    • Pitt, Bertram;
    • Dickstein, Kenneth;
    • Pfeffer, Marc A.;
    • Girerd, Nicolas;
    • Rossignol, Patrick;
    • Ferreira, João Pedro;
    • Zannad, Faiez
    Publication type:
    Article
    7

    Non-fatal cardiovascular events preceding sudden cardiac death in patients with an acute myocardial infarction complicated by heart failure: insights from the high-risk myocardial infarction database.

    Published in:
    European Heart Journal: Acute Cardiovascular Care, 2021, p. 127, doi. 10.1093/ehjacc/zuaa012
    By:
    • Hui, Sonya K;
    • Sharma, Abhinav;
    • Docherty, Kieran;
    • McMurray, John J V;
    • Pitt, Bertram;
    • Dickstein, Kenneth;
    • Pfeffer, Marc A;
    • Girerd, Nicolas;
    • Rossignol, Patrick;
    • Ferreira, João Pedro;
    • Zannad, Faiez
    Publication type:
    Article
    8

    Front Cover.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 1, p. C1, doi. 10.1111/dom.15423
    By:
    • Perakakis, Nikolaos;
    • Bornstein, Stefan R.;
    • Birkenfeld, Andreas L.;
    • Linkermann, Andreas;
    • Demir, Münevver;
    • Anker, Stefan D.;
    • Filippatos, Gerasimos;
    • Pitt, Bertram;
    • Rossing, Peter;
    • Ruilope, Luis M.;
    • Kolkhof, Peter;
    • Lawatscheck, Robert;
    • Scott, Charlie;
    • Bakris, George L.
    Publication type:
    Article
    9

    Efficacy of finerenone in patients with type 2 diabetes, chronic kidney disease and altered markers of liver steatosis and fibrosis: A FIDELITY subgroup analysis.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 1, p. 191, doi. 10.1111/dom.15305
    By:
    • Perakakis, Nikolaos;
    • Bornstein, Stefan R.;
    • Birkenfeld, Andreas L.;
    • Linkermann, Andreas;
    • Demir, Münevver;
    • Anker, Stefan D.;
    • Filippatos, Gerasimos;
    • Pitt, Bertram;
    • Rossing, Peter;
    • Ruilope, Luis M.;
    • Kolkhof, Peter;
    • Lawatscheck, Robert;
    • Scott, Charlie;
    • Bakris, George L.
    Publication type:
    Article
    10
    11

    Back Cover.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 10, p. C4, doi. 10.1111/dom.15286
    By:
    • Rossing, Peter;
    • Anker, Stefan D.;
    • Filippatos, Gerasimos;
    • Pitt, Bertram;
    • Ruilope, Luis M.;
    • Billings, Liana K.;
    • Green, Jennifer B.;
    • Koya, Daisuke;
    • Mosenzon, Ofri;
    • Pantalone, Kevin M.;
    • Ahlers, Christiane;
    • Lage, Andrea;
    • Lawatscheck, Robert;
    • Scalise, Andrea;
    • Bakris, George L.
    Publication type:
    Article
    12

    The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the FIDELITY study.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 10, p. 2989, doi. 10.1111/dom.15197
    By:
    • Rossing, Peter;
    • Anker, Stefan D.;
    • Filippatos, Gerasimos;
    • Pitt, Bertram;
    • Ruilope, Luis M.;
    • Billings, Liana K.;
    • Green, Jennifer B.;
    • Koya, Daisuke;
    • Mosenzon, Ofri;
    • Pantalone, Kevin M.;
    • Ahlers, Christiane;
    • Lage, Andrea;
    • Lawatscheck, Robert;
    • Scalise, Andrea;
    • Bakris, George L.
    Publication type:
    Article
    13

    Cover Image.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1, doi. 10.1111/dom.15115
    By:
    • McGill, Janet B.;
    • Agarwal, Rajiv;
    • Anker, Stefan D.;
    • Bakris, George L.;
    • Filippatos, Gerasimos;
    • Pitt, Bertram;
    • Ruilope, Luis M.;
    • Birkenfeld, Andreas L.;
    • Caramori, Maria L.;
    • Brinker, Meike;
    • Joseph, Amer;
    • Lage, Andrea;
    • Lawatscheck, Robert;
    • Scott, Charlie;
    • Rossing, Peter
    Publication type:
    Article
    14

    Effects of finerenone in people with chronic kidney disease and type 2 diabetes are independent of HbA1c at baseline, HbA1c variability, diabetes duration and insulin use at baseline.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1512, doi. 10.1111/dom.14999
    By:
    • McGill, Janet B.;
    • Agarwal, Rajiv;
    • Anker, Stefan D.;
    • Bakris, George L.;
    • Filippatos, Gerasimos;
    • Pitt, Bertram;
    • Ruilope, Luis M.;
    • Birkenfeld, Andreas L.;
    • Caramori, Maria L.;
    • Brinker, Meike;
    • Joseph, Amer;
    • Lage, Andrea;
    • Lawatscheck, Robert;
    • Scott, Charlie;
    • Rossing, Peter
    Publication type:
    Article
    15

    Front Cover.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 3, p. C1, doi. 10.1111/dom.14995
    By:
    • Rossing, Peter;
    • Garweg, Justus G.;
    • Anker, Stefan D.;
    • Osonoi, Takeshi;
    • Pitt, Bertram;
    • Rosas, Sylvia E.;
    • Ruilope, Luis Miguel;
    • Zhu, Dalong;
    • Brinker, Meike;
    • Finis, David;
    • Leal, Sergio;
    • Schmelter, Thomas;
    • Bakris, George
    Publication type:
    Article
    16

    Effect of finerenone on the occurrence of vision‐threatening complications in patients with non‐proliferative diabetic retinopathy: Pooled analysis of two studies using routine ophthalmological examinations from clinical trial participants (ReFineDR/DeFineDR)

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 3, p. 894, doi. 10.1111/dom.14915
    By:
    • Rossing, Peter;
    • Garweg, Justus G.;
    • Anker, Stefan D.;
    • Osonoi, Takeshi;
    • Pitt, Bertram;
    • Rosas, Sylvia E.;
    • Ruilope, Luis Miguel;
    • Zhu, Dalong;
    • Brinker, Meike;
    • Finis, David;
    • Leal, Sergio;
    • Schmelter, Thomas;
    • Bakris, George
    Publication type:
    Article
    17

    Front Cover.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. C1, doi. 10.1111/dom.14960
    By:
    • Rossing, Peter;
    • Agarwal, Rajiv;
    • Anker, Stefan D.;
    • Filippatos, Gerasimos;
    • Pitt, Bertram;
    • Ruilope, Luis M.;
    • Fonseca, Vivian;
    • Umpierrez, Guillermo E.;
    • Caramori, Maria Luiza;
    • Joseph, Amer;
    • Lambelet, Marc;
    • Lawatscheck, Robert;
    • Bakris, George L.
    Publication type:
    Article
    18
    19
    20

    Dapagliflozin effects on lung fluid volumes in patients with heart failure and reduced ejection fraction: Results from the DEFINE‐HF trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 6, p. 1426, doi. 10.1111/dom.14352
    By:
    • Nassif, Michael E.;
    • Windsor, Sheryl L.;
    • Tang, Fengming;
    • Husain, Mansoor;
    • Inzucchi, Silvio E.;
    • McGuire, Darren K.;
    • Pitt, Bertram;
    • Scirica, Benjamin M.;
    • Austin, Bethany;
    • Fong, Michael W.;
    • LaRue, Shane J.;
    • Umpierrez, Guillermo;
    • Hartupee, Justin;
    • Khariton, Yevgeniy;
    • Malik, Ali O.;
    • Ogunniyi, Modele O.;
    • Wenger, Nanette K.;
    • Kosiborod, Mikhail N.
    Publication type:
    Article
    21

    Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes: A Mediation Analysis.

    Published in:
    Annals of Internal Medicine, 2023, v. 176, n. 12, p. 1606, doi. 10.7326/M23-1023
    By:
    • Agarwal, Rajiv;
    • Tu, Wanzhu;
    • Farjat, Alfredo E.;
    • Farag, Youssef M.K.;
    • Toto, Robert;
    • Kaul, Sanjay;
    • Lawatscheck, Robert;
    • Rohwedder, Katja;
    • Ruilope, Luis M.;
    • Rossing, Peter;
    • Pitt, Bertram;
    • Filippatos, Gerasimos;
    • Anker, Stefan D.;
    • Bakris, George L.;
    • Vallejos, Augusto;
    • MacIsaac, Richard;
    • Schernthaner, Guntram;
    • Gillard, Pieter;
    • Canziani, Maria Eugenia F.;
    • Temelkova-Kurktschiev, Theodora
    Publication type:
    Article
    22
    23
    24

    A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease.

    Published in:
    European Heart Journal, 2016, v. 37, n. 27, p. 2105, doi. 10.1093/eurheartj/ehw132
    By:
    • Filippatos, Gerasimos;
    • Anker, Stefan D.;
    • BÃhm, Michael;
    • Gheorghiade, Mihai;
    • KÃber, Lars;
    • Krum, Henry;
    • Maggioni, Aldo P.;
    • Ponikowski, Piotr;
    • Voors, Adriaan A.;
    • Zannad, Faiez;
    • So-Young Kim;
    • Nowack, Christina;
    • Palombo, Giovanni;
    • Kolkhof, Peter;
    • Kimmeskamp-Kirschbaum, Nina;
    • Pieper, Alexander;
    • Pitt, Bertram
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38

    Introduction.

    Published in:
    European Heart Journal, 2011, v. 13, n. suppl_B, p. B1
    By:
    • Pitt, Bertram
    Publication type:
    Article
    39
    40
    41
    42
    43
    44

    Kidney outcomes with finerenone: an analysis from the FIGARO-DKD study.

    Published in:
    Nephrology Dialysis Transplantation, 2023, v. 38, n. 2, p. 372, doi. 10.1093/ndt/gfac157
    By:
    • Ruilope, Luis M;
    • Pitt, Bertram;
    • Anker, Stefan D;
    • Rossing, Peter;
    • Kovesdy, Csaba P;
    • Pecoits-Filho, Roberto;
    • Pergola, Pablo;
    • Joseph, Amer;
    • Lage, Andrea;
    • Mentenich, Nicole;
    • Scheerer, Markus F;
    • Bakris, George L
    Publication type:
    Article
    45

    Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post hoc analyses from FIDELIO-DKD compared to reported CREDENCE results.

    Published in:
    Nephrology Dialysis Transplantation, 2022, v. 37, n. 7, p. 1261, doi. 10.1093/ndt/gfab336
    By:
    • Agarwal, Rajiv;
    • Anker, Stefan D;
    • Filippatos, Gerasimos;
    • Pitt, Bertram;
    • Rossing, Peter;
    • Ruilope, Luis M;
    • Boletis, John;
    • Toto, Robert;
    • Umpierrez, Guillermo E;
    • Wanner, Christoph;
    • Wada, Takashi;
    • Scott, Charlie;
    • Joseph, Amer;
    • Ogbaa, Ike;
    • Roberts, Luke;
    • Scheerer, Markus F;
    • Bakris, George L
    Publication type:
    Article
    46
    47

    Association of Finerenone Use With Reduction in Treatment-Emergent Pneumonia and COVID-19 Adverse Events Among Patients With Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Pooled Secondary Analysis.

    Published in:
    JAMA Network Open, 2022, v. 5, n. 10, p. e2236123, doi. 10.1001/jamanetworkopen.2022.36123
    By:
    • Pitt, Bertram;
    • Agarwal, Rajiv;
    • Anker, Stefan D.;
    • Ruilope, Luis M.;
    • Rossing, Peter;
    • Ahlers, Christiane;
    • Brinker, Meike;
    • Joseph, Amer;
    • Lambelet, Marc;
    • Lawatscheck, Robert;
    • Filippatos, Gerasimos S.
    Publication type:
    Article
    48
    49
    50